{"id":768718,"date":"2023-07-10T17:47:47","date_gmt":"2023-07-10T21:47:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/"},"modified":"2023-07-10T17:47:47","modified_gmt":"2023-07-10T21:47:47","slug":"novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/","title":{"rendered":"NOVOCURE INVESTOR ALERT: Kaplan Fox &amp; Kilsheimer LLP Notifies NovoCure Investors of a Class Action Lawsuit and Upcoming Deadline"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, July  10, 2023  (GLOBE NEWSWIRE) &#8212; Kaplan Fox &amp; Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors of NovoCure Limited (\u201cNovoCure\u201d or the \u201cCompany\u201d) (NASDAQ: NVCR) securities between January 5, 2023 and June 5, 2023, inclusive (the \u201cClass Period\u201d). <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cRkB9XfPqY3LFjaMAUXw7nNS59Q1KUwPy_SPt6kDaIHdkJPM9Ti1Pj_4KAvm75-5dD_hJ7ukrJ3JHFZKrS4H60YVjlEnPwFRKaYfy_EidCKNN16fkPOwXDgkhD2hpjGGF53EKn-BNLRGqPy5a72YGQ==\" rel=\"nofollow noopener\" target=\"_blank\">Click Here to Join Investigation.<\/a><\/p>\n<p align=\"justify\">\n        <strong>If you acquired NovoCure securities during the Class Period and would like to discuss this case, please <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-VAvmgCZhwhlOzYGsBIY9dRT2dL1z2rB2jpoVVltBcg3na-G0HpDFSoK4hRPnaTxQSvjcI8aXkB3HqzDkTvIMVBfomWs11518sknHGz3smNBB0j3-XbwXbJEAW_Vq_Jf\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <strong>click here<\/strong><br \/>\n        <\/a><br \/>\n        <strong>. You may also contact us by emailing <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WOGde0uAuCTfq9s-EGPc9ENsnNHwxRQBRRYJf6wA94eWAOzma8eE-th9afDnUvmkf1ngYQqjAQWDZgOyrMNgTCvP9vADY0ACVZZ2gL4U8jg=\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <strong>pmayer@kaplanfox.com<\/strong><br \/>\n        <\/a><br \/>\n        <strong> or calling (646) 315-9003.<\/strong>\n      <\/p>\n<p align=\"justify\">If you are a member of the proposed Class, you may move the court <strong>no later than August 18, 2023<\/strong> to serve as a lead plaintiff for the purported class.\u00a0 If you have losses, we encourage you to contact us to learn more about the lead plaintiff process.<\/p>\n<p align=\"justify\">On January 5, 2023, defendants announced topline results from the Company\u2019s LUNAR Study, including that the study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in overall survival over standard therapies alone. Additionally, NovoCure allegedly represented that \u201c[t]he LUNAR Study also showed a statistically significant and clinically meaningful improvement in overall survival when patients were treated with TTFields and immune checkpoint inhibitors alone.\u201d According to the complaint, the Company concealed the true nature of the LUNAR study results because \u201cthe overwhelmingly positive way that the Company described [the results] was only a half-truth at best.\u201d<\/p>\n<p align=\"justify\">According to the complaint, on June 6, 2023, the long-anticipated presentation of NovoCure\u2019s LUNAR study\u2019s full results were presented at the American Society of Clinical Oncology\u2019s annual meeting. While the results were positive on the whole, allegedly there was an underlying problem with the data set utilized in the study because a relatively small percentage of study participants had been receiving standard of care therapy (i.e., immune checkpoint inhibitors), thereby rendering the study\u2019s results unreliable in terms of demonstrating clinical efficacy.<\/p>\n<p align=\"justify\">Following this news, NovoCure\u2019s stock price dropped $35.51 per share, or 43%, to close at $47 per share on June 6, 2023.<\/p>\n<p align=\"justify\">\n        <strong>WHY CONTACT KAPLAN FOX<\/strong> &#8211; Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in complex litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox &amp; Kilsheimer LLP, you may visit our website at www.kaplanfox.com.<\/p>\n<p align=\"justify\">This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p>\n<p align=\"justify\">If you have any questions about this Notice, your rights, or your interests, please contact:<\/p>\n<p align=\"justify\">Pamela Mayer<br \/>KAPLAN FOX &amp; KILSHEIMER LLP<br \/>800 Third Avenue, 38th Floor<br \/>New York, New York\u00a010022<br \/>(646) 315-9003<br \/>E-mail: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WOGde0uAuCTfq9s-EGPc9ENsnNHwxRQBRRYJf6wA94ctPgiahYlKEsvo_HbyIuFJGGp2fxTUtERtW1k7TFVEWDi-QFLGj6dXhd0kOtF6dME=\" rel=\"nofollow noopener\" target=\"_blank\">pmayer@kaplanfox.com<\/a><\/p>\n<p>Laurence D. King<br \/>KAPLAN FOX &amp; KILSHEIMER LLP<br \/>1999 Harrison Street, Suite 1560<br \/>Oakland, California 94612<br \/>(415) 772-4704<br \/>Fax:\u00a0 (415) 772-4707<br \/>E-mail: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Iim9KxPXSWABKysrE5qEURUQRTdTSG0UcgNtw-apE0kaqiOBafKu4xYRAgR-6lzNm0h0xr6sw2EB6xqW-B5vLZbFDgB6OvFOJfIiwmMdglw=\" rel=\"nofollow noopener\" target=\"_blank\">lking@kaplanfox.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MTg5OCM1Njg1MTc3IzIwMjA4OTE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MTczYjBmZTEtYTNiNC00MzVlLWIzZWQtYWQyMGZjMWU2ZGJhLTEwMzE5OTk=\/tiny\/Kaplan-Fox-Kilsheimer-LLP.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, July 10, 2023 (GLOBE NEWSWIRE) &#8212; Kaplan Fox &amp; Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors of NovoCure Limited (\u201cNovoCure\u201d or the \u201cCompany\u201d) (NASDAQ: NVCR) securities between January 5, 2023 and June 5, 2023, inclusive (the \u201cClass Period\u201d). Click Here to Join Investigation. If you acquired NovoCure securities during the Class Period and would like to discuss this case, please click here . You may also contact us by emailing pmayer@kaplanfox.com or calling (646) 315-9003. If you are a member of the proposed Class, you may move the court no later than August 18, 2023 to serve as a lead plaintiff for the purported class.\u00a0 If you have losses, we encourage &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NOVOCURE INVESTOR ALERT: Kaplan Fox &amp; Kilsheimer LLP Notifies NovoCure Investors of a Class Action Lawsuit and Upcoming Deadline&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-768718","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NOVOCURE INVESTOR ALERT: Kaplan Fox &amp; Kilsheimer LLP Notifies NovoCure Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NOVOCURE INVESTOR ALERT: Kaplan Fox &amp; Kilsheimer LLP Notifies NovoCure Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, July 10, 2023 (GLOBE NEWSWIRE) &#8212; Kaplan Fox &amp; Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors of NovoCure Limited (\u201cNovoCure\u201d or the \u201cCompany\u201d) (NASDAQ: NVCR) securities between January 5, 2023 and June 5, 2023, inclusive (the \u201cClass Period\u201d). Click Here to Join Investigation. If you acquired NovoCure securities during the Class Period and would like to discuss this case, please click here . You may also contact us by emailing pmayer@kaplanfox.com or calling (646) 315-9003. If you are a member of the proposed Class, you may move the court no later than August 18, 2023 to serve as a lead plaintiff for the purported class.\u00a0 If you have losses, we encourage &hellip; Continue reading &quot;NOVOCURE INVESTOR ALERT: Kaplan Fox &amp; Kilsheimer LLP Notifies NovoCure Investors of a Class Action Lawsuit and Upcoming Deadline&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-10T21:47:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MTg5OCM1Njg1MTc3IzIwMjA4OTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NOVOCURE INVESTOR ALERT: Kaplan Fox &amp; Kilsheimer LLP Notifies NovoCure Investors of a Class Action Lawsuit and Upcoming Deadline\",\"datePublished\":\"2023-07-10T21:47:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/\"},\"wordCount\":507,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3MTg5OCM1Njg1MTc3IzIwMjA4OTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/\",\"name\":\"NOVOCURE INVESTOR ALERT: Kaplan Fox &amp; Kilsheimer LLP Notifies NovoCure Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3MTg5OCM1Njg1MTc3IzIwMjA4OTE=\",\"datePublished\":\"2023-07-10T21:47:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3MTg5OCM1Njg1MTc3IzIwMjA4OTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3MTg5OCM1Njg1MTc3IzIwMjA4OTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NOVOCURE INVESTOR ALERT: Kaplan Fox &amp; Kilsheimer LLP Notifies NovoCure Investors of a Class Action Lawsuit and Upcoming Deadline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NOVOCURE INVESTOR ALERT: Kaplan Fox &amp; Kilsheimer LLP Notifies NovoCure Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/","og_locale":"en_US","og_type":"article","og_title":"NOVOCURE INVESTOR ALERT: Kaplan Fox &amp; Kilsheimer LLP Notifies NovoCure Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk","og_description":"NEW YORK, July 10, 2023 (GLOBE NEWSWIRE) &#8212; Kaplan Fox &amp; Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors of NovoCure Limited (\u201cNovoCure\u201d or the \u201cCompany\u201d) (NASDAQ: NVCR) securities between January 5, 2023 and June 5, 2023, inclusive (the \u201cClass Period\u201d). Click Here to Join Investigation. If you acquired NovoCure securities during the Class Period and would like to discuss this case, please click here . You may also contact us by emailing pmayer@kaplanfox.com or calling (646) 315-9003. If you are a member of the proposed Class, you may move the court no later than August 18, 2023 to serve as a lead plaintiff for the purported class.\u00a0 If you have losses, we encourage &hellip; Continue reading \"NOVOCURE INVESTOR ALERT: Kaplan Fox &amp; Kilsheimer LLP Notifies NovoCure Investors of a Class Action Lawsuit and Upcoming Deadline\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/","og_site_name":"Market Newsdesk","article_published_time":"2023-07-10T21:47:47+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MTg5OCM1Njg1MTc3IzIwMjA4OTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NOVOCURE INVESTOR ALERT: Kaplan Fox &amp; Kilsheimer LLP Notifies NovoCure Investors of a Class Action Lawsuit and Upcoming Deadline","datePublished":"2023-07-10T21:47:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/"},"wordCount":507,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MTg5OCM1Njg1MTc3IzIwMjA4OTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/","name":"NOVOCURE INVESTOR ALERT: Kaplan Fox &amp; Kilsheimer LLP Notifies NovoCure Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MTg5OCM1Njg1MTc3IzIwMjA4OTE=","datePublished":"2023-07-10T21:47:47+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MTg5OCM1Njg1MTc3IzIwMjA4OTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MTg5OCM1Njg1MTc3IzIwMjA4OTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novocure-investor-alert-kaplan-fox-kilsheimer-llp-notifies-novocure-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NOVOCURE INVESTOR ALERT: Kaplan Fox &amp; Kilsheimer LLP Notifies NovoCure Investors of a Class Action Lawsuit and Upcoming Deadline"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/768718","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=768718"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/768718\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=768718"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=768718"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=768718"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}